HAEM5:Acute myeloid leukaemia with DEK::NUP214 fusion: Difference between revisions
| [checked revision] | [checked revision] |
Bailey.Glen (talk | contribs) No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Acute myeloid leukaemia with DEK::NUP214 fusion}} | {{DISPLAYTITLE:Acute myeloid leukaemia with DEK::NUP214 fusion}} | ||
[[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | [[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | ||
| Line 12: | Line 13: | ||
Jennelle C. Hodge, PhD, FACMG | Jennelle C. Hodge, PhD, FACMG | ||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||
| Line 49: | Line 49: | ||
| | | | ||
|} | |} | ||
<nowiki>*</nowiki>Note: These are only the genetic/genomic criteria. Additional diagnostic criteria can be found in the [https://tumourclassification.iarc.who.int/home <u>WHO Classification of Tumours</u>]. | <nowiki>*</nowiki>Note: These are only the genetic/genomic criteria. Additional diagnostic criteria can be found in the [https://tumourclassification.iarc.who.int/home <u>WHO Classification of Tumours</u>]. | ||
==Related Terminology== | ==Related Terminology== | ||
| Line 63: | Line 65: | ||
==Gene Rearrangements== | ==Gene Rearrangements== | ||
[[File:T(6;9)(p23;q34).png]] | |||
Put your text here and fill in the table <span style="color:#0070C0">(''Instructions: Details on clinical significance such as prognosis and other important information can be provided in the notes section. Please include references throughout the table. Do not delete the table.'')</span> | Put your text here and fill in the table <span style="color:#0070C0">(''Instructions: Details on clinical significance such as prognosis and other important information can be provided in the notes section. Please include references throughout the table. Do not delete the table.'')</span> | ||
{| class="wikitable sortable" | {| class="wikitable sortable" | ||